Well just look at the last P&L statement that Black put out in September that showed the company was profitable. The profits should be much higher this quarter from the HNS Fund and the additional benefits from the "accretive" dilution program. And, who knows, those German company's looking at the Microfill could have already placed some orders for it that we aren't aware of. And all this progress I am sure hasn't gone unnoticed by the big boys. I am sure that Pfizer, Merck, J&J, Boston Scientific, etc. etc. are well aware of what's going on with HNSS and are ready to pounce on this undervalued gem!!! A buyout would be the icing on the cake for all of us die hard longs!!!! Go HNSS!!!!
News 
Market Data 
Discover 
